Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validación Del método de análisis Automatizado Del Habla "AcceXible" Para la detección Temprana y Seguimiento de Pacientes Con Deterioro Cognitivo Leve o Demencia en atención Primaria.

NCT05380297 is registered in ClinicalTrials.gov with Accexible as lead sponsor.

NCT NCT05380297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05380297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validación Del método de análisis Automatizado Del Habla "AcceXible" Para la detección Temprana y Seguimiento de Pacientes Con Deterioro Cognitivo Leve o Demencia en atención Primaria.
Lead sponsor
Accexible
Phase
Not applicable
Overall status
Completed
Start date
May 17, 2021
Completion date
April 18, 2024
Enrollment
273 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, mild cognitive impairment